Home / Stocks / INM

INM insider trading

InMed Pharmaceuticals Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
10
Bought · 24 mo
$1.4M
Buys · last 90 days
5 · $204k
Most recent buy
2026-10-20

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-10-20ADAR1 Capital Management, LLC
10% owner
Bought1,087$1.32$1k
2026-10-15ADAR1 Capital Management, LLC
10% owner
Bought9,569$1.33$13k
2026-10-08ADAR1 Capital Management, LLC
10% owner
Bought10,903$1.33$14k
2026-10-05ADAR1 Capital Management, LLC
10% owner
Bought42,920$1.33$57k
2026-09-16ADAR1 Capital Management, LLC
10% owner
Bought91,101$1.30$118k
2026-07-17ADAR1 Capital Management, LLC
10% owner
Bought1,000$1.55$2k
2026-07-16Vivo Opportunity Cayman Fund, L.P.
10% owner
Bought20,546$1.55$32k
2026-07-02Vivo Opportunity Cayman Fund, L.P.
10% owner
Bought6,551$1.55$10k
2026-06-10Vivo Opportunity Cayman Fund, L.P.
10% owner
Bought249,227$1.57$392k
2026-05-21ADAR1 Capital Management, LLC
10% owner
Bought468,551$1.54$722k

Most active insider buyers

InsiderRoleBuysTotal bought
ADAR1 Capital Management, LLC10% owner7$927k
Vivo Opportunity Cayman Fund, L.P.10% owner3$434k

See INM on the chart

Every insider buy and sell for INM plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.